Lixte Biotechnology Stock Forward View

Lixte Biotechnology Additional Predictive Modules

Most predictive techniques to examine Lixte price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lixte using various technical indicators. When you analyze Lixte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. A naive forecasting model for Lixte Biotechnology is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Lixte Biotechnology Holdings value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Lixte Biotechnology Naive Prediction Price Forecast For the 23rd of February

Given 90 days horizon, the Naive Prediction forecasted value of Lixte Biotechnology Holdings on the next trading day is expected to be 0.01 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0004, and the sum of the absolute errors of 0.92.

Lixte Biotechnology Stock Forecast Pattern

Backtest Lixte Biotechnology

Lixte Biotechnology Price Prediction

Research Analysis

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Lixte Biotechnology stock data series using in forecasting. Note that when a statistical model is used to represent Lixte Biotechnology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. This model is not at all useful as a medium-long range forecasting tool of Lixte Biotechnology Holdings. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Lixte Biotechnology. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Lixte Biotechnology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lixte Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.00 0.02 48.68 Details

Intrinsic Valuation Low Real High 0.00 0.02 48.68 Details

Bollinger Band Projection (param) Low Middle High -0.48 0.04 0.56 Details

Lixte Biotechnology After-Hype Price Density Analysis

Lixte Biotechnology Estimiated After-Hype Price Volatility

Lixte Biotechnology Stock Price Outlook Analysis

Notes

Lixte Biotechnology Hype Timeline

Lixte Biotechnology is now traded for 0.02. The entity has historical hype elasticity of 0.17, and average elasticity to hype of competition of 0.01. Lixte is anticipated to increase in value after the next headline, with the price projected to jump to 0.023 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 4.16%, whereas the daily expected return is now at 23.05%. The volatility of related hype on Lixte Biotechnology is about 7486153.85%, with the expected price after the next announcement by competition of 0.03. Lixte Biotechnology Holdings has accumulated about 1.08 M in cash with (3.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Assuming the 90 days horizon the next anticipated press release will be in about 24 days. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Lixte Biotechnology Related Hype Analysis

Lixte Biotechnology Related Equities

Risk & Return

Correlation

Lixte Biotechnology Market Strength Events

Lixte Biotechnology Risk Indicators

Story Coverage note for Lixte Biotechnology

Lixte Biotechnology Short Properties

Other Consideration for investing in Lixte Stock